Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Lung cancer is the most common malignancy and leads to around one-quarter of all cancer deaths. Great advances have been achieved in the treatment of lung cancer with novel anticancer agents and improved technology. However, morbidity and mortality rates remain extremely high, calling for an urgent need to develop novel anti-lung cancer agents. 1,2,3-Triazole could be readily interact with diverse enzymes and receptors in organisms through weak interaction. 1,2,3-Triazole can not only be acted as a linker to tether different pharmacophores but also serve as a pharmacophore. This review aims to summarize the recent advances in 1,2,3-triazole-containing compounds with anti-lung cancer potential, and their structure-activity relationship (SAR) together with mechanisms of action is also discussed to pave the way for the further rational development of novel anti-lung cancer candidates.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8226129 | PMC |
| http://dx.doi.org/10.3389/fphar.2021.661173 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Metal-Free, Regiodivergent -Alkylation of 1-Indazoles Enabled by Brønsted Acid Catalysis.
Org Lett
September 2025
School of Petrochemical Engineering, Changzhou University, Changzhou, Jiangsu 213164, P. R. China.
The catalytic -selective functionalization of indazoles is pivotal in medicinal chemistry; however, achieving regiodivergent -alkylation remains challenging due to the aromatic stabilization and tautomeric equilibrium of indazoles. Herein, we report a metal-free, Brønsted acid-catalyzed alkylation of 1-indazoles using sulfoxonium ylides, which affords excellent -selectivity and good yields. Modulation of the catalyst enables switchable /-alkylation.
View Article and Find Full Text PDFCo-delivery of icariside II and doxorubicin by self-assembled carrier-free nanofibers for anti-lung cancer therapy.
J Mater Chem B
September 2025
Shanghai University of Traditional Chinese Medicine, Shanghai 201203, China.
Icariside II (ICAII), a bioactive compound derived from Epimedii Folium, exhibits promising anti-tumor activity but encounters challenges in its clinical application due to its poor solubility and low bioavailability. Thus, this study developed a novel carrier-free co-delivery system of ICAII and doxorubicin (DOX) through their self-assembly into nanofibers. ICAII combined with DOX nanofibers (ICAII-DOX NFs), and ICAII-DOX/TPGS NFs (with TPGS as a stabilizer) were systematically characterized for their physicochemical properties, including size distribution, morphology, and molecular interactions.
View Article and Find Full Text PDFAnti-Lung Cancer Effects and Related Mechanisms of α-Caryophyllene In Vitro and In Vivo.
Food Sci Nutr
September 2025
α-Caryophyllene is a natural condiment and flavoring additive. Herein, we first study the in vivo and in vitro anti-lung cancer efficacy of α-caryophyllene and its potential mechanism. In antitumor activity in vitro, α-caryophyllene exhibited obvious selective cytotoxicity, and its cytotoxicity against lung cancer A549 cells (IC = 22.
View Article and Find Full Text PDFc-MET Inhibition Reverses the Osimertinib Resistance in Lung Circulating Tumor Cell Clusters and Suppresses Metastasis.
Biol Proced Online
August 2025
Institute of Oncology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, 200071, China.
Background: Circulating tumor cells (CTCs) serve as the “seeds” of tumor metastasis, and the clustering of CTCs is critically associated with tumor metastasis and the mortality of lung cancer patients. Inhibiting the survival of CTC clusters represents a pivotal strategy for anti-lung cancer metastasis therapy. This study is designed to explore the impact and underlying mechanism of lung cancer CTC clusters in mediating resistance to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), thereby offering novel insights into anti-lung cancer metastasis treatment.
View Article and Find Full Text PDFHydroxamic Acid Hybrids for Lung Cancer Therapy.
Arch Pharm (Weinheim)
August 2025
School of Pharmacy, Xianning Medical College, Hubei University of Science and Technology, Xianning, Hubei, China.
Lung cancer is one of the most common and deadly cancers across the world nowadays, and the morbidity and mortality of lung cancer will continue to increase for a long period. Chemotherapy, which can kill cancer cells, shrink tumors, and improve patient survival and quality of life, plays a crucial role in lung cancer therapy. However, chemotherapy has several disadvantages, mainly manifested in severe side effects, limited efficacy, and the tendency to develop drug resistance.
View Article and Find Full Text PDF